TrialClinical pharmacology and therapeutics2021

How Semiphysiological Population Pharmacokinetic Modeling Incorporating Active Hepatic Uptake Supports Phase II Dose Selection of RO7049389, A Novel Anti-Hepatitis B Virus Drug.

Valérie Cosson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.